Manuscripts
Showing 1543 manuscripts.
Induction of cytokines in normal placental cells by the human immunodeficiency virus
Citation
James M. Reuben, B. Gonik, Siyu Li, Jim A. Turpin. Induction of cytokines in normal placental cells by the human immunodeficiency virus. Lymphokine and Cytokine Research. 1991. 10: 195-9.Year
1991
Journal
Lymphokine and Cytokine Research
A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease
Citation
Ross E. McKinney. A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease. New England Journal of Medicine. 1991. 324: 1018-1025.Year
1991
Journal
New England Journal of Medicine
Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection
Citation
T. Tartaglione, T. Tartaglione, Ann C. Collier, Kent Opheim, F. G. Gianola, Jacqueline K. Benedetti, Lawrence Corey. Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. 1991. 35: 2225-31.Year
1991
Journal
Antimicrobial Agents and Chemotherapy
Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men
Citation
Walter T. Hughes, Wren Kennedy, Jerry L. Shenep, Patricia M. Flynn, Seth Hetherington, Glenda H. Fullen, Danny Lancaster, Daniel S. Stein, Steven Palte, Deborah Rosenbaum, San H.T. Liao, M. Robert Blum, Michael D. Rogers. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. Journal of Infectious Diseases. 1991. 163: 843-8.Year
1991
Journal
Journal of Infectious Diseases
A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma
Citation
Margaret A. Fischl, Raj B. Uttamchandani, Lionel Resnick, Ram Agarwal, Mary Ann Fletcher, Janie Reese, Lisa Dearmas, Jane Chidekel, Mary McCann, Mark Myers. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 1-10.Year
1991
Journal
Journal of Acquired Immune Deficiency Syndromes
Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS
Citation
Susan E. Krown, Donna Niedzwiecki, R. B. Bhalla, Neal Flomenberg, Denise Bundow, D. Chapman. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 871-80.Year
1991
Journal
Journal of Acquired Immune Deficiency Syndromes
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus
Citation
David H. Schwartz, Gail Skowron, Thomas C. Merigan. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 11-23.Year
1991
Journal
Journal of Acquired Immune Deficiency Syndromes
Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients
Citation
Charles Rinaldo, Charles Rinaldo, Xiao-Li Huang, P. Piazza, John A. Armstrong, G. Rappocciolo, George J. Pazin, Deborah McMahon, Phalguni Gupta, Z. Fan, Zhi-Qiang Zhang. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. Journal of Infectious Diseases. 1991. 164: 638-45.Year
1991
Journal
Journal of Infectious Diseases
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
Citation
Charles Flexner, Patricia Barditch-Crovo, David Kornhauser, Homayoon Farzadegan, Lynda Nerhood, Richard E. Chaisson, Kathleen M. Bell, Kevin Lorentsen, Craig Hendrix, Brent Gray Petty, Paul S. Lietman. Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. 1991. 35: 2544-50.Year
1991
Journal
Antimicrobial Agents and Chemotherapy
Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis
Citation
Kenneth A. Freedberg, AN Tosteson, Calvin J. Cohen, Deborah Jean Cotton. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 521-31.Year
1991
Journal
Journal of Acquired Immune Deficiency Syndromes